Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer A comparative plan analysis

被引:7
|
作者
Song, C. [2 ,4 ]
Pyo, H. [1 ]
Kim, J. [1 ]
Lim, Y. K. [2 ]
Kim, W. C. [3 ]
Kim, H. J. [4 ]
Kim, D. W. [2 ]
Cho, K. H. [2 ]
机构
[1] Sungkyunkwan Univ, Dept Radiat Oncol, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
[2] Res Inst & Hosp, Proton Therapy Ctr, Natl Canc Ctr, Goyang, South Korea
[3] Inha Univ, Dept Radiat Oncol, Sch Med, Inchon, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
关键词
Non-small cell lung cancer; Helical tomotherapy; Intensity-modulated radiotherapy; Radiation pneumonitis; Radiation dosage; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; DOSE-ESCALATION; IMRT TECHNIQUES; NORMAL TISSUE; PNEUMONITIS; IRRADIATION; TOXICITY; RISK; CHEMOTHERAPY;
D O I
10.1007/s00066-012-0159-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To compare helical tomotherapy (HT) and conventional intensity-modulated radiotherapy (IMRT) using a variety of dosimetric and radiobiologic indexes in patients with locally advanced non-small cell lung cancer (LA-NSCLC). A total of 20 patients with LA-NSCLC were enrolled. IMRT plans with 4-6 coplanar beams and HT plans were generated for each patient. Dose distributions and dosimetric indexes for the tumors and critical structures were computed for both plans and compared. Both modalities created highly conformal plans. They did not differ in the volumes of lung exposed to > 20 Gy of radiation. The average mean lung dose, volume receiving a parts per thousand yenaEuro parts per thousand 30 Gy, and volume receiving a parts per thousand yenaEuro parts per thousand 10 Gy in HT planning were 18.3 Gy, 18.5%, and 57.1%, respectively, compared to 19.4 Gy, 25.4%, and 48.9%, respectively, with IMRT (p = 0.004, p < 0.001, and p < 0.001). The differences between HT and IMRT in lung volume receiving a parts per thousand yenaEuro parts per thousand 10-20 Gy increased significantly as the planning target volume (PTV) increased. For 6 patients who had PTV greater than 700 cm(3), IMRT was superior to HT for 5 patients in terms of lung volume receiving a parts per thousand yenaEuro parts per thousand 5-20 Gy. The integral dose to the entire thorax in HT plans was significantly higher than in IMRT plans. HT gave significantly better control of mean lung dose and volume receiving a parts per thousand yenaEuro parts per thousand 30-40 Gy, whereas IMRT provided better control of the lung volume receiving a parts per thousand yenaEuro parts per thousand 5-15 Gy and the integral dose to entire thorax. In most patients with PTV greater than 700 cm(3), IMRT was superior to HT in terms of lung volume receiving a parts per thousand yenaEuro parts per thousand 5-20 Gy. It is therefore advised that caution should be exercised when planning LA-NSCLC using HT.
引用
收藏
页码:901 / 909
页数:9
相关论文
共 50 条
  • [41] Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients
    Imano, Nobuki
    Kimura, Tomoki
    Kawahara, Daisuke
    Nishioka, Riku
    Fukumoto, Wataru
    Kawano, Reo
    Kubo, Katsumaro
    Katsuta, Tsuyoshi
    Takeuchi, Yuki
    Nishibuchi, Ikuno
    Murakami, Yuji
    Horimasu, Yasushi
    Masuda, Takeshi
    Fujitaka, Kazunori
    Hattori, Noboru
    Nagata, Yasushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1729 - 1735
  • [42] Patient selection, inter-fraction plan robustness and reduction of toxicity risk with deep inspiration breath hold in intensity-modulated radiotherapy of locally advanced non-small cell lung cancer
    Fjellanger, Kristine
    Rossi, Linda
    Heijmen, Ben J. M.
    Pettersen, Helge Egil Seime
    Sandvik, Inger Marie
    Breedveld, Sebastiaan
    Sulen, Turid Husevag
    Hysing, Liv Bolstad
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience
    Jiang, Zhi-Qin
    Yang, Kunyu
    Komaki, Ritsuko
    Wei, Xiong
    Tucker, Susan L.
    Zhuang, Yan
    Martel, Mary K.
    Vedam, Sastray
    Balter, Peter
    Zhu, Guangying
    Gomez, Daniel
    Lu, Charles
    Mohan, Radhe
    Cox, James D.
    Liao, Zhongxing
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 332 - 339
  • [44] Use of chemo-radiotherapy in locally advanced non-small cell lung cancer
    Novello, S
    Le Chevalier, T
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) : 292 - 299
  • [45] Definitive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Dose and Fractionation
    Dagoglu, Nergiz
    Karaman, Sule
    Arifoglu, Alptekin
    Kucucuk, Seden
    Oral, Ethem N.
    BALKAN MEDICAL JOURNAL, 2014, 31 (04) : 278 - 285
  • [46] Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base
    Jegadeesh, Naresh
    Liu, Yuan
    Gillespie, Theresa
    Fernandez, Felix
    Ramalingam, Suresh
    Mikell, John
    Lipscomb, Joseph
    Curran, Walter J.
    Higgins, Kristin A.
    CLINICAL LUNG CANCER, 2016, 17 (05) : 398 - 405
  • [47] Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
    Liao, Zhongxing
    Lee, J. Jack
    Komaki, Ritsuko
    Gomez, Daniel R.
    O'Reilly, Michael S.
    Fossella, Frank V.
    Blumenschein, George R., Jr.
    Heymach, John V.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Allen, Pamela K.
    Choi, Noah Chan
    DeLaney, Thomas F.
    Hahn, Stephen M.
    Cox, James D.
    Lu, Charles S.
    Mohan, Radhe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1813 - +
  • [48] Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study
    Ji, K.
    Zhao, L. J.
    Liu, W. S.
    Liu, Z. Y.
    Yuan, Z. Y.
    Pang, Q. S.
    Wang, J.
    Wang, P.
    BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1035)
  • [49] Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis
    Viani, Gustavo A.
    Gouveia, Andre G.
    Louie, Alexander, V
    Arcidiacono, Fabio
    Simone II, Charles B.
    Tsakiridis, Theodoros
    Hamamura, Ana Carolina
    Anselmo, Paola
    Moraes, Fabio Y.
    RADIOTHERAPY AND ONCOLOGY, 2024, 201
  • [50] Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage III non-small cell lung cancer
    Kong, Moonkyoo
    Hong, Seong Eon
    ONCOTARGETS AND THERAPY, 2016, 9 : 7227 - 7234